Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
10.3802/jgo.2020.31.e43
Author:
Ning ZHANG
1
;
Hanjie WANG
;
Jili YANG
Author Information
1. Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng, China.
Publication Type:Letter
MeSH:
Cervical Intraepithelial Neoplasia
From:Journal of Gynecologic Oncology
2020;31(2):43-